A dataset supporting Combinatorial Proteome Integral Solubility/Stability Alteration Analysis (CoPISA)
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Combination therapies are widely used in acute myeloid leukemia (AML), but systematic datasets capturing proteome-wide responses to multi-drug perturbations remain limited. Here we present CoPISA (Combinatorial Proteome Integral Solubility/Stability Alteration), a quantitative proteomics assay designed to profile protein solubility and stability responses to single and combined drug treatments. The dataset includes two AML drug pairs (LY3009120–sapanisertib and ruxolitinib–ulixertinib) applied to four AML cell lines (MOLM-13, MOLM-16, SKM-1, and NOMO-1) under control, single-agent, and combination conditions in both lysate and intact-cell formats. Thermal solubility profiling coupled with TMT-based multiplexed LC–MS/MS generated 16 TMT16-plex experiments comprising 192 LC–MS/MS raw files, providing deep proteome coverage across treatments and biological contexts. The resource includes raw and processed proteomics data, detailed experimental metadata in Sample and Data Relationship Format (SDRF), and reproducible analysis scripts for reporter normalization, protein-level aggregation, statistical modeling, and classification of combinatorial response patterns. The experimental design enables identification of proteins responding uniquely to combination treatments as well as overlapping single-agent effects. Technical validation demonstrates reproducible quantification across multiplex experiments and assay formats. All data are publicly available through the PRIDE repository (PXD066812) together with analysis code, enabling independent reanalysis and method development. This dataset provides a benchmark resource for studying proteome responses to drug combinations, comparing lysate and intact-cell perturbation profiles, developing computational approaches for combinatorial target inference, and supporting training in computational proteomics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We assembled a harmonized corpus of 24 publicly available thermal-shift proteomics datasets, covering TPP, PISA, and i-PISA, together with our in-house CoPISA dataset (20, 20, 21).”
From DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay (2026) · cites this paper as [20]
In the citing paper
“A subset of DORSSAA directly derives from our recent combinatorial therapy study in 4 AML cell lines and includes 4 single drugs and 2 drug combinations (20, 21).”
From DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay (2026) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRIDE: The proteomics identifications database
Martens, L., Hermjakob, H., Jones, P., Adamski, M., Taylor, C., States, D., Gevaert, K., Vandekerckhove, J., & Apweiler, R. (2005) · PROTEOMICS · doi:10.1002/pmic.200401303 · Cited by 594
Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease
Ping, L., Kundinger, S. R., Duong, D. M., Yin, L., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2020) · Scientific Data · doi:10.1038/s41597-020-00650-8 · Cited by 127
DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay
Zangene, E., Gholizadeh, E., Schwämmle, V., Saei, A. A., Wilhelm, M., Käll, L., & Jafari, M. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101603 · Cited by 3
Self-citation
Research works printed but not linked: 24
- Cherry, E. M. et al. Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia. Blood Adv. 5, 5565–5573 (2021). · DOI · Paper page
- Barneh, F. et al. Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer. Brief Bioinform 20, 717–731 (2019). · DOI · Paper page
- Gholizadeh, E. et al. Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus. Mol Pharmacol 99, 308–318 (2021). · DOI · Paper page
- Tyner, J. et al. Functional genomic landscape of acute myeloid leukemia. Nature 562, 526–531 (2018). · DOI · Paper page
- Mirzaie, M. et al. Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling. Oncogenesis 13, 11 (2024). · DOI · Paper page
- Barneh, F. et al. Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology. J Cell Biochem 119, 9270–9283 (2018). · DOI · Paper page
- Gholizadeh, E. et al. Targeting acute myeloid leukemia resistance with two novel combinations demonstrate superior efficacy in TP53, HLA-B, MUC4 and FLT3 mutations. Biomedicine & Pharmacotherapy 192, 118647 (2025). · DOI
- Jafari, M., Ansari-Pour, N., Azimzadeh, S. & Mirzaie, M. A logic-based dynamic modeling approach to explicate the evolution of the central dogma of molecular biology. PLoS One 12, e0189922 (2017). · DOI
- Gholizadeh, E. et al. Solubility based mechanistic profiling of combinatorial drug therapy. Nat. Commun. 17, (2026). · DOI · Paper page
- Dai, C. et al. A proteomics sample metadata representation for multiomics integration and big data analysis. Nat. Commun. 12, 5854 (2021). · DOI · Paper page
- Claeys, T. et al. lesSDRF is more: maximizing the value of proteomics data through streamlined metadata annotation. Nat. Commun. 14, 6743 (2023). · DOI
- Zangene, E., Marashi, S.-A. & Montazeri, H. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks. Sci Rep 13, 15763 (2023). · DOI · Paper page
- Montazeri, H. et al. Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens. Nucleic Acids Res. 49, 8488–8504 (2021). · DOI · Paper page
- Webel, H., Perez-Riverol, Y., Nielsen, A. B. & Rasmussen, S. Mass spectrometry-based proteomics data from thousands of HeLa control samples. Scientific Data 11, 112 (2024). · DOI
- Vadadokhau, U. et al. Preventing Proteomics Data Tombs Through Collective Responsibility and Community Engagement. Sci Data 13, (2026). · DOI · Paper page
- Nickchi, P. et al. Monitoring Functional Posttranslational Modifications Using a Data-Driven Proteome Informatic Pipeline. Proteomics 25, e202400238 (2025). · DOI
- Nickchi, P., Jafari, M. & Kalantari, S. PEIMAN 1.0: Post-translational modification Enrichment, Integration and Matching ANalysis. Database (Oxford) 2015, bav037 (2015). · DOI
- Jafari, M., Guan, Y., Wedge, D. C. & Ansari-Pour, N. Re-evaluating experimental validation in the Big Data Era: a conceptual argument. Genome Biol 22, 71 (2021). · DOI · Paper page
- Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84–87 (2013). · DOI · Paper page
- Gaetani, M. et al. Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution. J Proteome Res 18, 4027–4037 (2019). · DOI · Paper page
- Zangene, E., Schwämmle, V. & Jafari, M. Informative Missingness in Nominal Data: A Graph-Theoretic Approach to Revealing Hidden Structure. Comput Struct Biotechnol J 35, 0099 (2026). · DOI · Paper page
- Jafari, M., Sadeghi, M., Mirzaie, M., Marashi, S.-A. & Rezaei-Tavirani, M. Evolutionarily conserved motifs and modules in mitochondrial protein-protein interaction networks. Mitochondrion 13, 668–675 (2013). · DOI
- Ansari-Pour, N., Razaghi-Moghadam, Z., Barneh, F. & Jafari, M. Testis-Specific Y-Centric Protein-Protein Interaction Network Provides Clues to the Etiology of Severe Spermatogenic Failure. J Proteome Res 15, 1011–1022 (2016). · DOI
- Jafari, M., Mirzaie, M., Sadeghi, M., Marashi, S.-A. & Rezaei-Tavirani, M. Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data. Biochim Biophys Acta 1834, 1063–1069 (2013). · doi:10.1016/j.bbapap.2013.02.003
Cited by
DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay
Zangene, E., Gholizadeh, E., Schwämmle, V., Saei, A. A., Wilhelm, M., Käll, L., & Jafari, M. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101603 · Cited by 3
Self-citation
Metadata
- Authors
- Zangene, E., Gholizadeh, E., Vadadokhau, U., Ritz, D., Saei, A. A., & Jafari, M.
- Venue
- Scientific Data
- Published
- 2026-06-29
- Volume
- 13
- Issue
- 1
- ISSN
- 2052-4463
- Cited by
- 3
- References
- 3
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 115 d)
- Funders
- Jane ja Aatos Erkon Säätiö (220031)
- Tampere Institute for Advanced Study
- Research Council of Finland (332454)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A dataset supporting Combinatorial Proteome Integral Solubility/Stability Alteration Analysis (CoPISA). https://app.cochat.ai/papers/10.1038/s41597-026-07756-5
- The paper
- Zangene, E., Gholizadeh, E., Vadadokhau, U., Ritz, D., Saei, A. A., & Jafari, M. (2026). A dataset supporting Combinatorial Proteome Integral Solubility/Stability Alteration Analysis (CoPISA). Scientific Data. https://doi.org/10.1038/s41597-026-07756-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.